Beacon Investment Advisory Services’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.64M | Sell |
12,229
-85
| -0.7% | -$16.3K | 0.1% | 110 |
|
|
2026
Q1 | $2.26M | Sell |
12,314
-360
| -3% | -$66.3K | 0.09% | 111 |
|
|
2025
Q4 | $2.23M | Sell |
12,674
-256
| -2% | -$41.8K | 0.09% | 107 |
|
|
2025
Q3 | $1.81M | Hold |
12,930
| – | – | 0.08% | 111 |
|
|
2025
Q2 | $1.62M | Sell |
12,930
-3,150
| -20% | -$392K | 0.07% | 117 |
|
|
2025
Q1 | $2.2M | Sell |
16,080
-3,529
| -18% | -$504K | 0.1% | 108 |
|
|
2024
Q4 | $3M | Sell |
19,609
-4,001
| -17% | -$675K | 0.13% | 102 |
|
|
2024
Q3 | $4.58M | Sell |
23,610
-1,051
| -4% | -$220K | 0.19% | 92 |
|
|
2024
Q2 | $5.72M | Sell |
24,661
-1,593
| -6% | -$346K | 0.25% | 80 |
|
|
2024
Q1 | $5.66M | Sell |
26,254
-1,372
| -5% | -$321K | 0.24% | 80 |
|
|
2023
Q4 | $7.15M | Sell |
27,626
-1,126
| -4% | -$277K | 0.32% | 71 |
|
|
2023
Q3 | $7.39M | Sell |
28,752
-957
| -3% | -$256K | 0.36% | 67 |
|
|
2023
Q2 | $8.46M | Sell |
29,709
-645
| -2% | -$192K | 0.39% | 65 |
|
|
2023
Q1 | $8.44M | Sell |
30,354
-1,360
| -4% | -$376K | 0.41% | 61 |
|
|
2022
Q4 | $8.78M | Sell |
31,714
-6,254
| -16% | -$1.77M | 0.45% | 59 |
|
|
2022
Q3 | $10.1M | Sell |
37,968
-2,971
| -7% | -$631K | 0.56% | 53 |
|
|
2022
Q2 | $8.35M | Sell |
40,939
-2,157
| -5% | -$441K | 0.44% | 67 |
|
|
2022
Q1 | $9.08M | Sell |
43,096
-29,323
| -40% | -$6.38M | 0.39% | 68 |
|
|
2021
Q4 | $17.4M | Sell |
72,419
-6,549
| -8% | -$1.68M | 0.67% | 45 |
|
|
2021
Q3 | $22.3M | Sell |
78,968
-3,777
| -5% | -$1.24M | 0.93% | 31 |
|
|
2021
Q2 | $28.7M | Buy |
82,745
+923
| +1% | +$280K | 1.16% | 25 |
|
|
2021
Q1 | $22.9M | Buy |
81,822
+4,821
| +6% | +$1.3M | 1% | 32 |
|
|
2020
Q4 | $18.9M | Sell |
77,001
-3,379
| -4% | -$872K | 0.87% | 33 |
|
|
2020
Q3 | $22.8M | Buy |
80,380
+11,286
| +16% | +$3.15M | 1.18% | 26 |
|
|
2020
Q2 | $18.5M | Buy |
69,094
+15,118
| +28% | +$4.54M | 1.05% | 25 |
|
|
2020
Q1 | $17.1M | Sell |
53,976
-975
| -2% | -$296K | 1.2% | 25 |
|
|
2019
Q4 | $16.3M | Buy |
54,951
+52,391
| +2,047% | +$14.5M | 0.87% | 34 |
|
|
2019
Q3 | $596K | Buy |
2,560
+370
| +17% | +$86.2K | 0.06% | 141 |
|
|
2019
Q2 | $512K | Buy |
2,190
+450
| +26% | +$104K | 0.05% | 136 |
|
|
2019
Q1 | $411K | Sell |
1,740
-715
| -29% | -$225K | 0.04% | 164 |
|
|
2018
Q4 | $739K | Sell |
2,455
-250
| -9% | -$79.8K | 0.08% | 132 |
|
|
2018
Q3 | $956K | Sell |
2,705
-26
| -1% | -$8.95K | 0.09% | 120 |
|
|
2018
Q2 | $793K | Buy |
2,731
+26
| +1% | +$7.31K | 0.08% | 129 |
|
|
2018
Q1 | $741K | Buy |
2,705
+265
| +11% | +$82.3K | 0.08% | 132 |
|
|
2017
Q4 | $777K | Sell |
2,440
-119
| -5% | -$38.2K | 0.08% | 126 |
|
|
2017
Q3 | $801K | Buy |
+2,559
| New | +$758K | 0.07% | 140 |
|
Other funds holding BIIB
AIM
AAMU
ADEF
BPC
HP
Beacon Investment Advisory Services's BIIB Position: Q2 2026 in Review
Beacon Investment Advisory Services reduced its Biogen (BIIB) stake by 0.69% in Q2 2026, selling an estimated $16.3K and leaving 12,229 shares worth $2.64M. The position accounts for 0.1% of the portfolio, ranked #110.
Beacon Investment Advisory Services first reported a position in BIIB in Q3 2017 and has held it in 36 quarters since. The position peaked at $28.7M in Q2 2021. 269 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Beacon Investment Advisory Services held 12,229 shares of Biogen worth $2.64M as of Q2 2026.
- Beacon Investment Advisory Services sold 85 Biogen shares in Q2 2026, an estimated $16.3K.
- Biogen made up 0.1% of Beacon Investment Advisory Services's portfolio in Q2 2026, its #110 holding.
- Beacon Investment Advisory Services first reported a position in Biogen in Q3 2017 and has held it in 36 quarters since.
- Beacon Investment Advisory Services's Biogen position peaked at $28.7M in Q2 2021.
- 269 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Beacon Investment Advisory Services's 13F filing for Q2 2026, filed 8 Jul 2026.